Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Operating activities:
Net income	$ 67,538	$ 170,384
Loss from discontinued operations	21,203	1,758
Income from continuing operations	88,741	172,142
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation expense	11,247	11,328
Amortization and adjustments to operating lease assets	39,875	32,369
Depreciation	27,865	25,773
Amortization of intangible assets	7,555	7,686
Amortization of deferred debt issuance costs	1,548	1,174
Provision for bad debts	8,338	12,955
Deferred income taxes	(3,328)	1,441
Loss on disposals, accelerated depreciation, and adjustments to property and equipment	1,589	147
Realized and unrealized (gain) loss on investments	(2,002)	1,106
Realized gain on sale of assets	0	(4,779)
Unrealized gain on derivative	0	(83,832)
Changes in assets and liabilities:
Accounts receivable	5,314	(19,922)
Prepaid expenses and other current assets	(7,398)	(17,123)
Accounts payable	(104)	(18,495)
Accrued payroll and benefits	1,661	(6,291)
Accrued liabilities	8,649	(4,810)
Deferred revenue	25,081	24,103
Operating lease liabilities	(37,654)	(41,628)
Other assets and liabilities	(9,772)	(1,314)
Net cash provided by operating activities-continuing operations	167,205	92,030
Net cash (used in) provided by operating activities-discontinued operations	(23,042)	13,501
Net cash provided by operating activities	144,163	105,531
Investing activities:
Capital expenditures	(34,844)	(31,934)
Proceeds from sales of marketable securities	2,387	1,572
Purchases of marketable securities	(2,414)	(1,755)
Proceeds from sale of assets	0	6,421
Cash received on purchase price adjustment	0	92
Net cash used in investing activities-continuing operations	(34,871)	(25,604)
Net cash used in investing activities-discontinued operations	0	(3,803)
Net cash used in investing activities	(34,871)	(29,407)
Financing activities:
Proceeds from exercise of stock options	889	2,276
Employee taxes paid on withholding shares	(4,144)	(5,315)
Proceeds from stock issued under Colleague Stock Purchase Plan	160	0
Repurchases of common stock for treasury	(81,568)	(136,889)
Proceeds from long-term debt	800,000	225,000
Repayments of long-term debt	(2,250)	(177,250)
Payment of debt issuance costs	(18,047)	0
Proceeds from down payment on seller loan	0	5,200
Payment for purchase of redeemable noncontrolling interest of subsidiary	0	(6,247)
Net cash provided by (used in) financing activities-continuing operations	695,040	(93,225)
Net cash used in financing activities-discontinued operations	0	(2,920)
Net cash provided by (used in) financing activities	695,040	(96,145)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	343	(27,907)
Net increase (decrease) in cash, cash equivalents and restricted cash	804,675	(47,928)
Cash, cash equivalents and restricted cash at beginning of period	501,105	300,467
Cash, cash equivalents and restricted cash at end of period	1,305,780	252,539
Less: cash, cash equivalents and restricted cash of discontinued operations at end of period	0	83,961
Cash, cash equivalents and restricted cash at end of period	$ 1,305,780	$ 168,578